The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 07, 2018

Filed:

Dec. 07, 2012
Applicants:

Fundación Sales, Capital Federal, AR;

Consejo Nacional DE Investigaciones Científicas Y Técnicas, Capital Federal, AR;

Inventors:

Claudia L. Lanari, Buenos Aires, AR;

Victoria Wargon, Capital Federal, AR;

Paola Rojas, Capital Federal, AR;

Maria May, Capital Federal, AR;

Gonzalo Sequeira, Capital Federal, AR;

Assignee:

FUNDACION SALES, Capital Federal, AR;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/165 (2006.01); A61K 31/567 (2006.01); A61K 31/706 (2006.01); A61K 38/17 (2006.01); A61K 45/06 (2006.01); A61K 31/575 (2006.01); A61K 31/7068 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1783 (2013.01); A61K 31/165 (2013.01); A61K 31/567 (2013.01); A61K 31/575 (2013.01); A61K 31/706 (2013.01); A61K 31/7068 (2013.01); A61K 45/06 (2013.01); A61K 48/005 (2013.01);
Abstract

The present invention provides methods and compositions for treating cancer patients, and in particular, breast cancer patients, who are responsive to antiprogestin therapy, or who may be induced to be responsive to an antiprogestin therapy through the administration of a demethylation agent, optionally together with an HDAC inhibitor. Further, the present invention relates to a method of screening cancer patients using BCL-XL as a marker protein.


Find Patent Forward Citations

Loading…